Rare Diseases
Topics
- Anthrax
- Ataxia Telangiectasia
- Childhood Leukemia
- Congenital Muscular Dystrophy
- Cystic Fibrosis
- Esophageal Cancer
- Liver Cancer
- Malaria
- Mucopolysaccharidoses (MPS)
- Myasthenia Gravis
- Orphan Drugs
- Osteogenesis Imperfecta
- Pancreatic Cancer
- Spinal Muscular Atrophy
- Usher Syndrome
- Amyotrophic Lateral Sclerosis (ALS)
- Cooley's Anemia
- Hepatitis - A
- Muscular Dystrophy
- Pediatric Cardiomyopathy
- Primary Immunodeficiencies
- Transmissible Spongiform Encephalopathy (TSE)
- Tuberculosis
- Tuberculosis Vaccine
- Hodgkin's Disease
- Orthopox Viruses
- Paget's Disease
- Pediatric Cancer
- Spina Bifida
- Stomach Cancer
- Charcot-Marie-Tooth Disease
- Ovarian Cancer
- Sickle Cell Disease
- Dystonia
- Sudden Infant Death Syndrome
- Valley Fever
- Neuroblastoma
- West Nile Virus
- Neurofibromatosis
- Batten Disease
- Brain Cancer
- Vaginal Cancer
- Fragile X
- Huntington's Disease
- Hydrocephalus
- Rett Syndrome
- Tuberous Sclerosis
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions Frequently Asked Questions (FAQs)
- Overview
- Request for Applications (RFA)
- Technical Assistance (TA) Webinar
- NIH RFA Contacts
- FAQs (Includes new FAQs as of 8/08/24)
Overview
NIH created the Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions Program in response to the Children’s Health Act of 2000.
Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs)
Overview
The Muscular Dystrophy Community Assistance, Research, and Education Amendments (MD-CARE Act) of 2001 (Public Law 107-84) aimed to expand and intensify research on muscular dystrophies (MDs). The Act included language directing NIH to establish centers of excellence for research on these diseases. The MDSRC program (formerly the Muscular Dystrophy Cooperative Research Centers program) was later named in honor of Senator Paul D.
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions
In June 2024, NIH published RFA-HD-25-002 : Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional).
Please note: In July 2024, NIH issued NOT-HD-24-026 : Notice to Extend the Application Receipt Date for RFA-HD-25-002, which extends the Request for Applications (RFA) deadline to August 20, 2024.
Molecular & Cellular Biology Laboratory
Genome Instability and Chromatin Remodeling Section
Weidong Wang , PhD, Chief
Neuromuscular Diseases Research Section
Bryan J. Traynor , M.D., Ph.D., Chief
The Neuromuscular Diseases Research Section investigates the causes and biology of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Our focus is on turning discoveries into better diagnosis and faster development of treatments. We combine large-scale human genetics with detailed molecular profiling to understand disease processes, improve patient grouping, and create biomarkers and outcome tools for clinical trials.
Circadian Biology of Aging Unit
Circadian Biology of Aging Unit
Victoria Acosta-Rodriguez, Ph.D., Chief
The CBAU will investigate how circadian clocks age and contribute to the onset of chronic diseases. Circadian clocks control 24h rhythms in physiology, energy cycles, immune function, and longevity-related pathways. Dysregulation in these endogenous time-keeping mechanisms, due to aging or lifestyle, is detrimental to health and lifespan.
Peter Basser Lab: Section on Quantitative Imaging and Tissue Sciences
We strive to understand fundamental relationships between function and structure in living tissues, primarily in neural tissue and in extracellular matrix (ECM). Specifically, we are interested in how microstructure, hierarchical organization, composition, and material properties all affect biological function and dysfunction. We investigate biological and physical model systems, such as “engineered” tissue constructs and tissue analogs at different time and length scales.
Dax Hoffman Lab: Section on Neurophysiology
The Hoffman group combines molecular, biochemical and electrophysiological approaches to investigate the roles of dendritic voltage-gated and neurotransmitter-activated channels in regulating neuronal development and synaptic plasticity in the mammalian hippocampus. To achieve this, the lab comprises an interdisciplinary team with expertise in cellular and molecular biology, biochemistry, electrophysiology, fluorescence imaging and computer modeling. These approaches allow us to assay channel function and regulation at the molecular scale in living cells.
Sergey Leikin Lab: Section on Physical Biochemistry
Welcome to Section on Physical Biochemistry @ NICHD.NIH
Our mission is to develop methods for diagnostics, monitoring and treatment of diseases based on better understanding their molecular mechanisms. We focus on the following studies: